Topic

Content with Topic Clinical Management .

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022
What is already known about this topic? A recent clinical trial identified a daily 4-month regimen ...

Good practices for selecting and procuring rapid diagnostic tests for malaria
   This manual provides guidance on the selection and procurement of quality-assured mala...

COVID-19 respiratory equipment
All health workers require knowledge and skills to care for patients safely and protect themselves f...

Screening for Lead during the Domestic Medical Examination for Newly Arrived Refugees
Background Lead is a known neurotoxicant, and exposure can result in EBLL 4. Around the world, incl...

Tuberculosis preventive treatment
   About a quarter of the world’s population is estimated to be infected with Mycobacte...

Definitions and reporting framework for tuberculosis
Standardization of definitions and reporting structures has permitted uniformity in the reporting of...

WHO treatment guidelines for drug-resistant tuberculosis, 2016 update
In November 2015, the World Health Organization (WHO) convened a meeting of a Guideline Development ...

Treatment and pharmaceutical prophylaxis of COVID-19
   Background Several medicinal products have been studied to assess their safety and ef...

Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
Summary of recent changes (last updated February 11, 2022) Added table for potential characterist...

Self-Study Modules on Tuberculosis
The Self-Study Modules on Tuberculosis are a series of educational modules designed to provide infor...

WHO updates its treatment guidelines to include molnupiravir
This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imde...

Safety in administering medicines for neglected tropical diseases
This course is based on the Manual on Safety in Administering Medicines for Neglected Tropical Disea...

Global Malaria Programme
The WHO Global Malaria Programme (GMP) is responsible for coordinating WHO's global efforts to contr...

Evusheld approved to prevent COVID-19 in people whose immune response is poor
The decision to grant approval for this treatment was endorsed by the government’s independent expe...

Improving healthcare associated infection surveillance
Improving healthcare associated infection surveillance A virtual training on surgical site infectio...

Guidelines for prevention and control of Chikungunya fever
Chikungunya is an emerging, epidemic-prone vector-borne disease of considerable significance in the...

Haemophilus influenzae Disease (Including Hib)
For Clinicians Etiologic agent Haemophilus influenzae is a pleomorphic gram-negative coccobacill...

Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region
This manual makes recommendations on a standardized approach for case management of cutaneous leishm...

World malaria report 2018
The World malaria report, published annually, provides a comprehensive update on global and reg...

Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
Summary Since April 2021, increased cases of myocarditis and pericarditis have been reported in th...



Topic
Site Map